Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
In the media 9 Sep 2026 Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements Swissinfo
Scientific articles 15 Aug 2026 Identification of new Trypanosoma cruzi-specific protein synthesis inhibitors by using a developed high-throughput in vitro translation assay International Journal for Parasitology: Drugs and Drug Resistance
Scientific articles 5 Aug 2026 ICH E21: from landmark guidance to specific action for maternal and child health
Scientific articles 3 Aug 2026 A Phase IIa, Proof-of-Concept, Placebo-Controlled, Randomised Trial to Investigate the Efficacy and Safety of Oxfendazole as a Macrofilaricidal Drug in Adults Harbouring Lymphatic Filarial Worms Infectious Diseases and Therapy
Press releases 22 Jul 2019 Patients treated for visceral leishmaniasis can still transmit the disease even after completing treatment, study shows
Press releases 17 Jul 2019 Nationwide hepatitis C screening campaign initiated by the Malaysian Ministry of Health
Press releases 20 Jun 2019 Chagas Access Programme achieves an increase of 1300% in the number of people screened
Press releases 24 May 2019 Following 110 years of neglect, an official day for Chagas disease is declared
Press releases 16 Apr 2019 DNDi and Atomwise collaborate to advance drug development using AI for neglected diseases
Press releases 14 Mar 2019 Study shows dramatically shorter treatment for Chagas disease could be just as effective, and significantly safer
Press releases 5 Feb 2019 Wellcome commits £10 million to DNDi to develop new generation of oral drugs to treat leishmaniasis
Press releases 30 Jan 2019 Fexinidazole, the first all-oral treatment for sleeping sickness, approved in Democratic Republic of Congo
Press releases 29 Jan 2019 MMV and DNDi make 400 compounds available to stimulate research into new drugs for pandemic diseases
Press releases 23 Jan 2019 Drugs for Neglected Diseases initiative and The BMJ launch a special collection on neglected diseases and innovation in South Asia
Press releases 17 Jan 2019 Combination therapy found to be more effective in treating patients with leishmaniasis and HIV
Press releases 16 Nov 2018 European Medicines Agency recommends fexinidazole, the first all-oral treatment for sleeping sickness
Press releases 12 Sep 2018 New hope for PKDL patients in Africa as clinical trial aims to make treatment safer and easier
Press releases 5 Sep 2018 DNDi and Fiocruz launch project to expand access to diagnosis and treatment for Chagas disease in Brazil
